Christopher von Seggern, Chief Commercial Officer at Xenon Pharmaceuticals Inc. (XENE), bought 4,000 shares at $24.40 ($98K) on 2021-12-06, disclosed to the SEC on 2021-12-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.